ResearcherIstituto Superiore di SanitàActive in the last 2 years

Giovanni Forte

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5779-9333; OpenAlex author ID A5065091264. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Relationship between heavy metals and miRNAs in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jtemb.2025.127754 ↗
Toxic Metal and Essential Element Concentrations in the Blood and Tissues of Pancreatic Ductal Adenocarcinoma Patients. Co-author DOI 10.3390/toxics12010032 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Pisano · 2 shared papers, 2024–2025 · strength 0.45
- Paper Relationship between heavy metals and miRNAs in pancreatic ductal adenocarcinoma. DOI 10.1016/j.jtemb.2025.127754 ↗
- Paper Toxic Metal and Essential Element Concentrations in the Blood and Tissues of Pancreatic Ductal Adenocarcinoma Patients. DOI 10.3390/toxics12010032 ↗
Roberto Madeddu · 2 shared papers, 2024–2025 · strength 0.45
- Paper Relationship between heavy metals and miRNAs in pancreatic ductal adenocarcinoma. DOI 10.1016/j.jtemb.2025.127754 ↗
- Paper Toxic Metal and Essential Element Concentrations in the Blood and Tissues of Pancreatic Ductal Adenocarcinoma Patients. DOI 10.3390/toxics12010032 ↗
Grazia Fenu · 1 shared paper, 2025 · strength 0.24
- Paper Relationship between heavy metals and miRNAs in pancreatic ductal adenocarcinoma. DOI 10.1016/j.jtemb.2025.127754 ↗
Alberto Porcu · 1 shared paper, 2024 · strength 0.21
- Paper Toxic Metal and Essential Element Concentrations in the Blood and Tissues of Pancreatic Ductal Adenocarcinoma Patients. DOI 10.3390/toxics12010032 ↗
Grazia Fenu · 1 shared paper, 2024 · strength 0.21
- Paper Toxic Metal and Essential Element Concentrations in the Blood and Tissues of Pancreatic Ductal Adenocarcinoma Patients. DOI 10.3390/toxics12010032 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.